ASPREE Cancer Endpoints Study
Showing 1 - 25 of >10,000
TofAcitinib in Routine Care Rheumatoid Arthritis-Cancer
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Jun 17, 2022
Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer
Completed
- Cancer Treated With Immune-checkpoint Inhibitors
- Immune checkpoint inhibitor
-
Bordeaux, FranceInstitut Bergonié, Comprehensive Cancer Center
Dec 6, 2021
Efficacy in Randomized Controlled Trials in Elderly Cancer
Active, not recruiting
- Cancer
- Elderly cancer patients
-
Bordeaux, FranceInstitut Bergonié
Feb 2, 2022
Subjects Treated for Metastatic Breast Cancer: Contribution of
Active, not recruiting
- Cancer
- Endocrine therapies
-
Bordeaux, FranceInsitut Bergonié
Feb 2, 2022
Metastatic Castration-resistant Prostate Cancer Trial in United States (drug, radiation, device)
Completed
- Metastatic Castration-resistant Prostate Cancer
- NKTR-214 (Cohort A)
- +6 more
-
Los Angeles, California
- +5 more
Nov 10, 2022
Newly Diagnosed Glioblastoma Trial in United States (SurVaxM)
Recruiting
- Newly Diagnosed Glioblastoma
- SurVaxM
-
San Francisco, California
- +9 more
Aug 23, 2022
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Scottsdale (Paricalcitol (Zemplar))
Active, not recruiting
- Pancreatic Cancer
- +4 more
- Paricalcitol (Zemplar)
-
Scottsdale, ArizonaHonorHealth Research Institute
Feb 16, 2022
Aspirin in Reducing Events in the Elderly
Active, not recruiting
- Functional Disability
- +6 more
- 100 mg enteric-coated aspirin
- Placebo
-
Birmingham, Alabama
- +46 more
Apr 2, 2021
Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel
Completed
- Pancreatic Cancer
- +4 more
- Ascorbic Acid
- +3 more
-
Scottsdale, ArizonaHonorHealth Research Institute
Feb 10, 2022
Treating Patients With Stage IV Breast Cancer
Active, not recruiting
- Central Nervous System Metastases
- +15 more
- hyperfractionated radiation therapy
- +2 more
-
North Chicago, IllinoisUniversity of Chicago
Dec 6, 2021
Patients With Retinoblastoma
Recruiting
- Retinoblastoma
- +4 more
- Biospecimen collection
- +4 more
-
Chicago, Illinois
- +10 more
Apr 20, 2022
Cervical Cancer Early Endpoints and Determinants
Completed
- Cervical Cancer
- +3 more
-
Oklahoma City, OklahomaUniversity of Oklahoma
Mar 12, 2020
Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy
Enrolling by invitation
- Gallbladder Cancer
- Minimally invasive surgery
-
Barcelona, SpainHospital del Mar
Sep 25, 2023
Sintilimab and Anlotinib in Combination With Chemo Trial in Xi'an (Sintilimab and anlotinib in combination with chemo)
Completed
- Sintilimab and Anlotinib in Combination With Chemotherapy
- Sintilimab and anlotinib in combination with chemotherapy
-
Xi'an, Shanxi, China
- +1 more
Aug 27, 2023
Lung Cancer, Ambulant, Malnourished Trial in Herlev (Home food-delivery service)
Completed
- Lung Cancer
- +2 more
- Home food-delivery service
-
Herlev, DenmarkHerlev University Hsopital
Dec 20, 2022
Breast Cancer Trial in Vancouver, Toronto (drug, other, procedure)
Completed
- Breast Cancer
- sunitinib malate
- +5 more
-
Vancouver, British Columbia, Canada
- +1 more
Sep 16, 2020
Advanced NSCLC Trial in Jinan (almonertinib)
Recruiting
- Advanced Non-small Cell Lung Cancer
-
Jinan, Shandong, ChinaDegan Lu
Sep 12, 2023
LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic
Recruiting
- Non Small Cell Lung Cancer
-
Los Angeles, California
- +5 more
Jun 9, 2022
Cancer in Inherited Bone Marrow Failure Syndromes
Recruiting
- Diamond Blackfan Anemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 24, 2023
Prostate Cancer Trial in Montreal (68Ga-HBED-CC-PSMA PET/CT)
Enrolling by invitation
- Prostate Cancer
- 68Ga-HBED-CC-PSMA PET/CT
-
Montreal, Quebec, CanadaJewish General Hospital
Oct 24, 2022
Pediatric Cancer Trial in Los Angeles, Wilmington, Houston (eSCCIP/eSCCIP-SP, Coping Space)
Not yet recruiting
- Pediatric Cancer
- eSCCIP/eSCCIP-SP
- Coping Space
-
Los Angeles, California
- +2 more
Nov 22, 2022
Hepatocellular Carcinoma, Cirrhosis Trial in Falls Church (Namenda)
Not yet recruiting
- Hepatocellular Carcinoma
- Cirrhosis
-
Falls Church, VirginiaInova Health Care Service
Aug 18, 2023